
Sign up to save your podcasts
Or


A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.
By Rahul Banerjee, MD4.8
2727 ratings
A panel of hematology leaders discusses the latest in ALL and T-cell ALL therapy, including TKI+blina combinations, venetoclax strategies, and the emerging role of CD7 CAR T-cell therapies in reshaping treatment paradigms.

136 Listeners

320 Listeners

498 Listeners

74 Listeners

119 Listeners

28 Listeners

1,142 Listeners

187 Listeners

22 Listeners

369 Listeners

52 Listeners

137 Listeners

51 Listeners

192 Listeners

30 Listeners